CSF Studies: Difference between revisions
No edit summary |
(→CSF) |
||
| Line 1: | Line 1: | ||
== | ==Tests== | ||
'''Standard''' | |||
#tube 1 gs and culture | #tube 1 gs and culture | ||
#2 protein glc | #2 protein glc | ||
| Line 5: | Line 6: | ||
#4 hold | #4 hold | ||
'''Additional''' | |||
#cryptoccal ag | #cryptoccal ag | ||
#india ink | #india ink | ||
Revision as of 06:19, 28 March 2011
Tests
Standard
- tube 1 gs and culture
- 2 protein glc
- 3 cell count w diff
- 4 hold
Additional
- cryptoccal ag
- india ink
- afb pcr
- rpr vdrl
- fungal cx
- viral cx
- pcr for herpes viridae
- ldh >40 suggests bact. Meningitis < 40 viral (neches -pediatrics 1968)
Correction
for each 1000 rbc dec prot. By 1mg/dl
actual WBC =counted WBC-RBC csfx (Wbc blood/Rbc blood).
When to ct before LP
- AMS
- focal deficit or papilledema
- head trauma (recent or remote)
- new onset seizure (except poss febrile seizure in child)
- HIV+
- IVDA only if other above findings are present.
- age over 60
When to treat infants under 4-6 weeks empirically for herpes encephalitis:
- csf pleocytosis consistent w/ encephalitis + 1 of the following:
- HSV skin eye or mouth manifest.
- focal neuro findings or seizure
- sepsis with pneumonitis or hepatitis
- mother w/ genital HSV at delivery
- consider for very toxic fever >39 EC.
Source
7/2/09 PANI
